This is relevant as PQR620 was active in ABC DLBCL cell lines, and the most common type, PCNSL, which is an aggressive type of extranodal lymphoma, for which PI3K/mTOR inhibitors are an area of clinical research [48]. The gene discussed is MTOR; the disease is primary central nervous system lymphoma.